We are live on ! Find out more
IMMP

Immutep
IMMP

6 hedge funds and large institutions have $1.02M invested in Immutep in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

25% less funds holding

Funds holding: 8 → 6 (-2)

37% less capital invested

Capital invested by funds: $1.61M → $1.02M (-$587K)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$10.1K
2
Renaissance Technologies
Renaissance Technologies
New York
+$8.99K
3
Wells Fargo
Wells Fargo
California
+$956

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$190K
2
PC
Polar Capital
United Kingdom
-$77.9K
3
CWM
Cornerstone Wealth Management
Missouri
-$43K
4
Deutsche Bank
Deutsche Bank
Germany
-$25K
5
VWM
Valley Wealth Managers
New Jersey
-$22K

IMMP Hedge Fund Activity: Q2 2019 in Review

6 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2019, worth a combined $1.02M — down 37% from $1.61M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMMP and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, opening a new position worth an estimated $10.1K. The largest seller was Morgan Stanley, cutting an estimated $190K.

  • 6 institutional investors held Immutep (IMMP) as of Q2 2019, down from 8 in Q1 2019.
  • Funds reported $1.02M of Immutep stock for Q2 2019, down 37% quarter-over-quarter.
  • 2 funds opened new Immutep positions in Q2 2019 and 4 closed out, a net change of -2 holders.
  • The largest Immutep buyer in Q2 2019 was UBS Group, an estimated $10.1K added.
  • The largest Immutep seller in Q2 2019 was Morgan Stanley, an estimated $190K sold.

Based on aggregated 13F filings for Q2 2019.